Nifty’s 0.46% fall leaves Indian equities exposed to crude and inflation risks

Indian equities enter Wednesday with sentiment still governed by the oil-inflation link rather than by a broad deterioration in domestic flows. Crude’s rise amid uncertainty over the US-Iran situation weakened the rupee and pushed the domestic bond yield higher, increasing the sensitivity of rate-linked and import-dependent sectors to the next inflation signals.

The previous session was stock-specific beneath the headline decline. Dr Reddy’s Laboratories, Eternal, Infosys, TCS, Titan and Eicher Motors were among the prominent gainers, while UltraTech Cement, Tata Consumer Products, Max Healthcare, State Bank of India and other financial names weighed on the market. The contrast suggests that earnings reactions and sector-specific concerns mattered more than indiscriminate risk reduction.

Pharma and healthcare gained support from a strong top-line update at Zydus Lifesciences, even though the company’s profit and margins fell sharply. IT was comparatively resilient as TCS and Infosys advanced, while consumer durables found support in Titan and related names.

Telecom and internet stocks lagged without a single company-specific explanation available in the material. FMCG and retail weakness was concentrated in names such as Tata Consumer Products and Nestle India. Cement and materials were pressured by UltraTech Cement and Grasim; the broader backdrop of higher crude and commodity-cost uncertainty likely added to the caution, but no company-specific cost guidance was available.

The most direct domestic trigger for Wednesday is the July CPI release, scheduled by the Ministry of Statistics and Programme Implementation for 4 pm. The available pre-release poll puts headline inflation at 4.4%, against 4.38% in June, with core inflation expected to rise to 4.01% from 3.9%. These are expectations, not the official release.

The combination of higher crude, a weaker rupee and a pending inflation print matters for Indian markets because it can influence expectations for the RBI’s policy path and bond-market pricing. The RBI is also preparing a Digital Payment Intelligence Platform for banks to address fraud, while the government has approved field trials and possible regular issuance of polymer ₹10 and ₹20 banknotes. SEBI has amended regulations relating to municipal debt securities.

The global setup is cautious. US equities ended lower as investors reassessed the prospects of a US-Iran understanding and waited for US inflation data. The Dow, S&P 500 and Nasdaq all declined, while Asian markets were described as mixed, with pressure in Hong Kong and mainland Chinese shares and gains in Japan and South Korea.

Brent’s move towards the high-$80s keeps the external pressure on India’s inflation, current-account and rupee outlook. The US 10-year Treasury yield rose to 4.71%, while the dollar index was little changed to slightly firmer. For Indian equities, the immediate transmission channels are crude-sensitive sectors, imported input costs and foreign portfolio positioning rather than a broad change in domestic growth expectations.

The earnings tape was mixed. Zydus Lifesciences reported revenue growth of 22% to ₹8,017 crore, but consolidated profit fell 36% to ₹939.8 crore and EBITDA margin contracted to 24.1% from 31.8%. A brokerage expectation cited before the result had placed the margin at 25.6%, making the reported margin a miss against that reference, even as the revenue performance was strong.

MRF’s revenue rose 9.6% to ₹8,415.5 crore, below a cited expectation of 12% growth, while EBITDA margin fell to 11.77%. Manappuram Finance reported consolidated profit of ₹584.5 crore and a 28.1% rise in net interest income to ₹1,723.8 crore in one reported account; another results update gave different NII and profit figures, so the exact reported numbers should be read with caution. The company also declared an interim dividend of ₹1 per share.

Siemens reported continuing-operations revenue growth of 14.8% to ₹4,713.7 crore and new orders growth of 16.5% to ₹6,328 crore. Operating profit margin declined to 7.6% from 11.0%, while headline profit benefited from a one-time gain from the sale of its Low Voltage Motors business. RVNL reported higher revenue and profit, with EBITDA also improving, while management commentary or fresh guidance was not available in the material.

Foreign portfolio investors remained net buyers for a third consecutive session, purchasing ₹258.55 crore of Indian equities on a provisional basis. Domestic institutional investors were also marginal net buyers at ₹24.77 crore. The combined support was modest relative to the market decline, indicating that flows cushioned sentiment but did not offset the effect of crude, currency and stock-specific selling.

The primary market remains active, with Shiprocket opening today and several mainboard and SME issues either still accepting bids or moving towards allotment and listing. That activity provides a separate source of demand, but the market’s near-term direction is more likely to be determined by the CPI release, crude prices and the response to the latest earnings.